Laekna (HKG:2105) will sell 17,636,000 new shares to at least six investors under a placing deal, according to a Thursday filing with the Hong Kong Exchange.
The biotechnology company will shell the shares at HK$13.36 apiece.
The shares represent 4.33% of Laekna's issued share capital, as enlarged by the placement.
Net proceeds, estimated at HK$230.3 million, will be used to speed up research for the company's LAE102 weight-loss drug, the filing stated.
Shares slid 9% during Thursday's morning trading.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。